This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2004 Apr;34(4):593-8.

doi: 10.1016/j.bone.2003.11.026.

Perspectives on glucocorticoid-induced osteoporosis

Ernesto Canalis¹, John P Bilezikian, Alberto Angeli, Andrea Giustina

Affiliations

PMID: 15050888
DOI: 10.1016/j.bone.2003.11.026

Review

Perspectives on glucocorticoid-induced osteoporosis

Ernesto Canalis et al. Bone. 2004 Apr.

. 2004 Apr;34(4):593-8.

doi: 10.1016/j.bone.2003.11.026.

Authors

Ernesto Canalis¹, John P Bilezikian, Alberto Angeli, Andrea Giustina

Affiliation

¹ Saint Francis Hospital and Medical Center, Hartford, CT 06105, USA. ecanalis@stfranciscare.org

PMID: 15050888
DOI: 10.1016/j.bone.2003.11.026

No abstract available

PubMed Disclaimer

Similar articles

Glucocorticoid-induced osteoporosis: prevention and treatment.
Werth VP. Werth VP. Rev Rhum Engl Ed. 1997 Jun 30;64(6 Suppl):84S-88S. Rev Rhum Engl Ed. 1997. PMID: 9273946 Review. No abstract available.
Effect of glucocorticoids on bone density.
Rehman Q, Lane NE. Rehman Q, et al. Med Pediatr Oncol. 2003 Sep;41(3):212-6. doi: 10.1002/mpo.10339. Med Pediatr Oncol. 2003. PMID: 12868121 Review.
[Clinical studies on glucocorticoid-induced osteoporosis].
Tanaka I, Oshima H. Tanaka I, et al. Nihon Rinsho Meneki Gakkai Kaishi. 2001 Aug;24(4):142-151. Nihon Rinsho Meneki Gakkai Kaishi. 2001. PMID: 16646164 Review. Japanese. No abstract available.
[Functional mechanism of glucocorticoid in bone turnover and bone structure].
Ikeda S, Akahoshi S, Sakai A, Nakamura T. Ikeda S, et al. Clin Calcium. 2006 Nov;16(11):1805-11. Clin Calcium. 2006. PMID: 17079846 Review. Japanese.
Glucocorticoids and the osteoclast.
Teitelbaum SL. Teitelbaum SL. Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 92):S37-9. Epub 2015 Oct 12. Clin Exp Rheumatol. 2015. PMID: 26458014 Review.

See all similar articles

Cited by

Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications.
Arnaldi G, Mancini T, Tirabassi G, Trementino L, Boscaro M. Arnaldi G, et al. J Endocrinol Invest. 2012 Apr;35(4):434-48. doi: 10.1007/BF03345431. J Endocrinol Invest. 2012. PMID: 22652826 Review.
Mechanisms of glucocorticoid action in bone.
Canalis E. Canalis E. Curr Osteoporos Rep. 2005 Sep;3(3):98-102. doi: 10.1007/s11914-005-0017-7. Curr Osteoporos Rep. 2005. PMID: 16131429 Review.
Novel approaches to bone comorbidity in Cushing's disease: an update.
Frara S, di Filippo L, Doga M, Loli P, Casanueva FF, Giustina A. Frara S, et al. Pituitary. 2022 Oct;25(5):754-759. doi: 10.1007/s11102-022-01252-w. Epub 2022 Jul 18. Pituitary. 2022. PMID: 35849272 Review.
Vertebral fractures at hospitalization predict impaired respiratory function during follow-up of COVID-19 survivors.
di Filippo L, Compagnone N, Frara S, Allora A, Doga M, Rovere Querini P, Cremona G, Giustina A. di Filippo L, et al. Endocrine. 2022 Aug;77(2):392-400. doi: 10.1007/s12020-022-03096-7. Epub 2022 Jun 8. Endocrine. 2022. PMID: 35676466
Bone complications in patients with Cushing's syndrome: looking for clinical, biochemical, and genetic determinants.
Trementino L, Appolloni G, Ceccoli L, Marcelli G, Concettoni C, Boscaro M, Arnaldi G. Trementino L, et al. Osteoporos Int. 2014 Mar;25(3):913-21. doi: 10.1007/s00198-013-2520-5. Epub 2013 Oct 15. Osteoporos Int. 2014. PMID: 24126765

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information